Mark. S. Silverberg
#158,221
Most Influential Person Now
Mark. S. Silverberg's AcademicInfluence.com Rankings
Mark. S. Silverbergbiology Degrees
Biology
#12327
World Rank
#15796
Historical Rank
Microbiology
#733
World Rank
#807
Historical Rank
Immunology
#820
World Rank
#843
Historical Rank

Download Badge
Biology
Mark. S. Silverberg's Degrees
- PhD Microbiology Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Mark. S. Silverberg Influential?
(Suggest an Edit or Addition)Mark. S. Silverberg's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease (2012) (4007)
- Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. (2005) (2917)
- A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene (2006) (2867)
- Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease (2008) (2621)
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci (2010) (2516)
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications (2006) (2504)
- Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis (2007) (1825)
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target (2015) (1329)
- Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (2011) (1315)
- Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease (2001) (820)
- Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease (2011) (747)
- Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease (2008) (674)
- Genome-wide association identifies multiple ulcerative colitis susceptibility loci (2010) (621)
- Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease. (2006) (618)
- Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study (2016) (555)
- Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. (2000) (532)
- Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis (2009) (512)
- Common variants in the NLRP3 region contribute to Crohn's disease susceptibility (2009) (498)
- Common variants at five new loci associated with early-onset inflammatory bowel disease (2009) (479)
- Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. (2004) (346)
- Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis (2013) (339)
- Association of host genome with intestinal microbial composition in a large healthy cohort (2016) (330)
- Complex host genetics influence the microbiome in inflammatory bowel disease (2014) (313)
- Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. (2009) (268)
- Inflammatory Bowel Disease Characteristics Among African Americans, Hispanics, and Non-Hispanic Whites: Characterization of a Large North American Cohort (2006) (264)
- High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis (2014) (250)
- IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis (2013) (234)
- Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease (2018) (233)
- Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. (2010) (225)
- Ulcerative colitis loci on chromosomes 1p36 and 12q15 identified by genome-wide association study (2008) (199)
- Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases (2015) (193)
- Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. (2012) (186)
- Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis (2013) (180)
- Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. (2010) (177)
- Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting (2020) (164)
- HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants (2014) (164)
- NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2 (2011) (162)
- A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. (2009) (161)
- Prevalence of CARD15/NOD2 Mutations in Caucasian Healthy People (2007) (156)
- Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease (2015) (156)
- The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases (2007) (155)
- A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci (2012) (148)
- Relationship Between Proximal Crohn's Disease Location and Disease Behavior and Surgery: A Cross-Sectional Study of the IBD Genetics Consortium (2013) (144)
- Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis (2009) (140)
- IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes (2018) (139)
- Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn’s disease (2009) (133)
- Cannabis use amongst patients with inflammatory bowel disease (2011) (132)
- Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease (2015) (131)
- Risk Factors for Low Bone Density in Crohn's Disease (2002) (129)
- Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohn's Disease, and Ulcerative Colitis Patients (2013) (117)
- Distinct and overlapping genetic loci in crohn's disease and ulcerative colitis: Correlations with pathogenesis (2011) (116)
- Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease (2012) (115)
- CARD15 and HLA DRB1 Alleles Influence Susceptibility and Disease Localization in Crohn's Disease (2004) (113)
- Genetic variation in myosin IXB is associated with ulcerative colitis. (2006) (108)
- Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease (2013) (108)
- A Population- and Family-Based Study of Canadian Families Reveals Association of HLA DRB1*0103 With Colonic Involvement in Inflammatory Bowel Disease (2003) (101)
- Future directions in inflammatory bowel disease management. (2014) (101)
- Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. (2017) (100)
- Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. (2014) (100)
- Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease (2012) (100)
- A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition. (2016) (99)
- Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype (2009) (99)
- Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease (2007) (98)
- Increased Intestinal Permeability is Associated with Later Development of Crohn's Disease. (2020) (94)
- Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis (2008) (93)
- Defects in Nicotinamide-adenine Dinucleotide Phosphate Oxidase Genes NOX1 and DUOX2 in Very Early Onset Inflammatory Bowel Disease (2015) (92)
- Development of an index to define overall disease severity in IBD (2016) (92)
- Analyzing the Human Microbiome: A “How To” guide for Physicians (2014) (88)
- A validated web‐based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables (2016) (86)
- The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis (2012) (82)
- Expression quantitative trait loci analysis identifies associations between genotype and gene expression in human intestine. (2013) (80)
- Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn's Disease. (2016) (79)
- Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior (2011) (79)
- Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake. (2015) (79)
- Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease. (2016) (78)
- Characterization of the Gut-Associated Microbiome in Inflammatory Pouch Complications Following Ileal Pouch-Anal Anastomosis (2013) (73)
- Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: An expert consensus report (2012) (71)
- Higher Activity of the Inducible Nitric Oxide Synthase Contributes to Very Early Onset Inflammatory Bowel Disease (2014) (71)
- Corrigendum: Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study (2009) (71)
- Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases (2020) (71)
- Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis. (2016) (70)
- C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. (2011) (70)
- Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16. (1998) (68)
- The IBD International Genetics Consortium Provides Further Evidence for Linkage to IBD4 and Shows Gene‐Environment Interaction (2005) (67)
- Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans. (2015) (67)
- Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies (2021) (67)
- Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population (2016) (64)
- Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis. (2011) (63)
- Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease (2017) (63)
- Granulocyte–Macrophage Colony-Stimulating Factor Autoantibodies: A Marker of Aggressive Crohn's Disease (2013) (61)
- Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population‐based cohort (2013) (61)
- Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data (2019) (61)
- Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis. (2012) (60)
- Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies (2001) (60)
- Genetic sharing and heritability of paediatric age of onset autoimmune diseases (2015) (59)
- Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis. (2020) (57)
- Protein-Tyrosine Phosphatase Sigma Is Associated with Ulcerative Colitis (2007) (55)
- Serological response to mRNA COVID-19 vaccines in IBD patients receiving biological therapies (2021) (55)
- Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group. (2020) (55)
- Genetic Variation in the Familial Mediterranean Fever Gene (MEFV) and Risk for Crohn's Disease and Ulcerative Colitis (2009) (54)
- Clinical, Serologic, and Genetic Factors Associated with Pyoderma Gangrenosum and Erythema Nodosum in Inflammatory Bowel Disease Patients (2014) (51)
- DEVELOPMENT AND VALIDATION OF A TEST TO MONITOR ENDOSCOPIC ACTIVITY IN PATIENTS WITH CROHN'S DISEASE BASED ON SERUM LEVELS OF PROTEINS. (2019) (50)
- Determinants of Intestinal Permeability in Healthy First-Degree Relatives of Individuals with Crohn's Disease (2015) (47)
- Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus. (2012) (47)
- Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysis (2016) (47)
- A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF. (2016) (47)
- A pleiotropic missense variant in SLC 39 A 8 is associated with Crohn ’ s disease and human gut microbiome composition Short Title : SLC 39 A 8 associated with CD and gut microbiome (2016) (46)
- Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis (2018) (45)
- Dietary Guidance for Patients with Inflammatory Bowel Disease from the International Organization for the Study of Inflammatory Bowel Disease. (2020) (44)
- Ileal pouch symptoms do not correlate with inflammation of the pouch. (2014) (44)
- A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis (2015) (44)
- Assessing disease activity in ulcerative colitis: Patients or their physicians? (2010) (43)
- MODIFIED 2-STAGE ILEAL POUCH-ANAL ANASTOMOSIS RESULTS IN LOWER RATE OF ANASTOMOTIC LEAK COMPARED TO TRADITIONAL 2-STAGE SURGERY FOR ULCERATIVE COLITIS Short title : Anastomotic leak in 2-Stage IPAA for UC (2016) (42)
- Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease (2012) (42)
- Sa2031 Accelerated Clearance of Serum Infliximab During Induction Therapy for Acute Ulcerative Colitis is Associated With Treatment Failure. (2012) (41)
- Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis (2017) (40)
- Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC) (2007) (39)
- Modified Two-stage Ileal Pouch-Anal Anastomosis Results in Lower Rate of Anastomotic Leak Compared with Traditional Two-stage Surgery for Ulcerative Colitis. (2016) (39)
- Gene Expression Changes Associated with Resistance to Intravenous Corticosteroid Therapy in Children with Severe Ulcerative Colitis (2010) (39)
- Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits. (2016) (38)
- Predictors of Outcome in Ulcerative Colitis (2015) (38)
- Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis. (2016) (37)
- FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects (2018) (36)
- Phenotype-Stratified Genetic Linkage Study Demonstrates that IBD2 Is an Extensive Ulcerative Colitis Locus (2006) (35)
- Preoperative Anti–tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch–anal Anastomosis (2016) (34)
- Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease. (2018) (34)
- IBD Genetic Risk Profile in Healthy First-Degree Relatives of Crohn's Disease Patients. (2016) (34)
- OCTNs: will the real IBD5 gene please stand up? (2006) (33)
- Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. (2021) (32)
- Extended haplotype association study in Crohn’s disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3 (2013) (32)
- Contribution of higher risk genes and European admixture to Crohn's disease in African Americans (2012) (32)
- Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2020) (31)
- Inflamed ulcerative colitis regions associated to MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target. (2021) (31)
- Phenotypic and Genotypic Characteristics of Inflammatory Bowel Disease in French Canadians: Comparison With a Large North American Repository (2009) (31)
- Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study (2021) (31)
- Serum Antibodies Associated with Complex Inflammatory Bowel Disease (2013) (30)
- Genetic effects on the commensal microbiota in inflammatory bowel disease patients (2019) (30)
- Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study (2016) (28)
- MAST3: a novel IBD risk factor that modulates TLR4 signaling (2008) (28)
- Serological markers associated with disease behavior and response to anti‐tumor necrosis factor therapy in ulcerative colitis (2015) (27)
- Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity (2018) (27)
- Psychobiological Subtypes of Ulcerative Colitis: pANCA Status Moderates the Relationship Between Disease Activity and Psychological Distress (2006) (26)
- Biomarkers as potential treatment targets in inflammatory bowel disease: A systematic review. (2015) (25)
- Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. (2018) (24)
- Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized Computed Tomography Scoring System (2018) (24)
- Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn’s Disease (2016) (24)
- Higher Rates of Dose Optimisation for Infliximab Responders in Ulcerative Colitis than in Crohn's disease. (2015) (24)
- Attachment, Childhood Abuse, and IBD-related Quality of Life and Disease Activity Outcomes (2014) (23)
- Common and rare variant prediction and penetrance of IBD in a large, multi-ethnic, health system-based biobank cohort. (2020) (23)
- The Prevalence and Clinical Associations of Subclinical Sacroiliitis in Inflammatory Bowel Disease. (2018) (23)
- Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy. (2014) (23)
- Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group. (2021) (22)
- Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease (2018) (22)
- Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis (2010) (21)
- Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis (2015) (21)
- Genetics and innate and adaptive immunity in IBD. (2014) (20)
- Progression and Management of Duodenal Neoplasia in Familial Adenomatous Polyposis: A Cohort Study. (2015) (20)
- Microbiome Heterogeneity Characterizing Intestinal Tissue and Inflammatory Bowel Disease Phenotype (2016) (20)
- Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population. (2012) (20)
- Population‐based case‐control study of alpha 1‐antitrypsin and SLC11A1 in Crohn's disease and ulcerative colitis (2008) (20)
- Sa2047 Association of Serum Infliximab and Antibodies to Infliximab to Long-Term Clinical Outcome in Acute Ulcerative Colitis (2012) (19)
- Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune mediated inflammatory diseases. (2022) (19)
- Microbial Disruption of Autophagy Alters Expression of the RISC Component AGO2, a Critical Regulator of the miRNA Silencing Pathway (2015) (18)
- Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. (2019) (17)
- Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. (2019) (17)
- Differential miRNA expression in ileal and colonic tissues reveals an altered immunoregulatory molecular profile in individuals with Crohn's disease versus healthy subjects. (2019) (17)
- Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. (2019) (17)
- Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease (2022) (17)
- Magnesium Metabolism Studies in Children with Chronic Inflammatory Disease of the Bowel (1985) (17)
- BASIC-ALIMENTARY TRACT Genetic Variation in Myosin IXB Is Associated With Ulcerative Colitis (2006) (16)
- Replication of genetic variation in the MYO9B gene in Crohn's disease. (2011) (16)
- Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease (2017) (15)
- Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. (2021) (15)
- Mediterranean-like dietary pattern associations with gut microbiome composition and sub-clinical gastrointestinal inflammation. (2022) (15)
- An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29 (2008) (15)
- Stricturing and Fistulizing Crohn’s Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease (2018) (15)
- The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007 fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study (2017) (15)
- Prevalence of genetic variants associated with inflammatory bowel disease in a healthy First Nations cohort (2012) (15)
- Genetics of inflammatory bowel disease: current status and future directions. (2006) (14)
- Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel Disease (2016) (14)
- What do changes in inflammatory bowel disease management mean for our patients? (2012) (14)
- Genetic Predictors of Benign Course of Ulcerative Colitis—A North American Inflammatory Bowel Disease Genetics Consortium Study (2016) (14)
- Anti-microbial antibody response is associated with future onset of Crohn's disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk. (2021) (14)
- The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn’s Disease (2018) (13)
- Erratum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (Nature Genetics (2011) 43 (246-252)) (2011) (13)
- Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis. (2020) (13)
- Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility (2022) (13)
- Ileal pouch–anal anastomosis for ulcerative colitis: a Canadian institution’s experience (2017) (13)
- The Unsolved Link of Genetic Markers and Crohn's Disease Progression: A North American Cohort Experience. (2019) (12)
- Celiac Disease Detected by Pouch Biopsy of a Patient With Ileal Pouch–Anal Anastomosis (2011) (12)
- Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn’s Disease (2016) (12)
- Microbiome analysis – from technical advances to biological relevance (2014) (12)
- Tu1327a Golimumab for Treatment of Moderate to Severe Anti-TNF Refaractory Crohn's Disease: Open Label Experience (2012) (11)
- Genome-wide association study identifies five novel susceptibility loci for Crohn ' s disease and implicates a role for autophagy in disease pathogenesis (2009) (11)
- Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects (2020) (11)
- COVID-19 Pandemic: Which IBD Patients Need to Be Scoped—Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal (2020) (11)
- Hypothesis-free analysis of ATG16L1 demonstrates gene-wide extent of association with Crohn's disease susceptibility (2012) (10)
- Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease (2021) (10)
- Su1858 – Real-World Effectiveness and Safety of Vedolizumab and Anti-TNF in Biologic-Naive Ulcerative Colitis Patients: Results from the Evolve Study (2019) (10)
- Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis. (2019) (10)
- Time to revisit disease classification in IBD: is the current classification of IBD good enough for optimal clinical management? (2021) (10)
- Association Between a Multi-Locus Genetic Risk Score and Inflammatory Bowel Disease (2013) (10)
- Functional interaction of ERAP2 and HLA-B27 activates the unfolded protein response (2016) (10)
- The impact of ulcerative colitis is greater in unmarried and young patients. (2007) (9)
- Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitis (2021) (9)
- Clinical features and genetic risk of demyelination following anti-TNF treatment. (2020) (9)
- Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment. (2020) (9)
- P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn’s disease patients: results from the EVOLVE study (2019) (9)
- Su1762 Clinical and Molecular Characterization of Medically Refractory Acute, Severe Colitis: Preliminary Results From the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC) Immunochip Study (2013) (9)
- Su1312 A Validated Web-Based Patient Communication Tool to Display Individualized Crohn's Disease Predicted Outcomes Based on Clinical, Serologic and Genetic Variables (2014) (8)
- Patients with Low Drug Levels or Antibodies to a Prior Anti-TNF Are More Likely to Develop Antibodies to a Subsequent Anti-TNF. (2021) (8)
- Inflammatory Bowel Disease-Gastroenterology Diamond Jubilee Review. (2018) (8)
- Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study (2017) (8)
- Serum Analyte Profiles Associated With Crohn's Disease and Disease Location. (2021) (8)
- Effect of inflammatory bowel disease therapies on immunogenicity of Mycobacterium paratuberculosis proteins (2014) (8)
- Sequencing of over 100,000 individuals identifies multiple genes and rare variants associated with Crohns disease susceptibility (2021) (8)
- Have Genomic Discoveries in Inflammatory Bowel Disease Translated into Clinical Progress? (2012) (8)
- Intraepithelial lymphocytosis is a frequent finding in biopsies from ileal pouch-anal anastomoses. (2016) (7)
- An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials (2021) (7)
- Attitudes toward genetic testing in patients with inflammatory bowel disease (2007) (7)
- Downregulation of Expression of Xenobiotic Efflux Genes is Associated with Pelvic Pouch Inflammation in Ulcerative Colitis (2014) (7)
- Association between the C3435T polymorphism of the MDR1 gene and Crohn's disease. (2006) (7)
- Sa1816 – Elevated Fecal Calprotectin in Healthy First Degree Relatives of Patients with Crohn's Disease is Associated with Future Diagnosis of Crohn's Disease (2019) (7)
- The time has come for NOD2/CARD15 testing for families with Crohn's disease: pro. (2005) (7)
- Erratum: Genome-wide association identifies multiple ulcerative colitis susceptibility loci (2011) (6)
- A role for CXCR3 ligands as biomarkers of post-operative Crohn's disease recurrence. (2021) (6)
- TNFRSF1B Is Associated with ANCA in IBD (2016) (6)
- Mucosa-Associated Microbiota in Ileoanal Pouches May Contribute to Clinical Symptoms, Particularly Stool Frequency, Independent of Endoscopic Disease Activity (2019) (6)
- Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin (2001) (6)
- Advancing Early Identification of Axial Spondyloarthritis: An Interobserver Comparison of Extended Role Practitioners and Rheumatologists (2019) (6)
- P789 Microbiome composition is altered in patients with IBD independent of endoscopic activity. (2017) (6)
- Identification of Target Golimumab Levels in Maintenance Therapy of Crohn's Disease and Ulcerative Colitis Associated With Mucosal Healing. (2020) (5)
- Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA–B27 Activates the Unfolded Protein Response (2017) (5)
- Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness (2018) (5)
- Integrative analysis of colonic biopsies from inflammatory bowel disease patients identifies an interaction between microbial bile-acid inducible gene abundance and human Angiopoietin-like 4 gene expression. (2021) (5)
- Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population (2019) (5)
- Prevalence of NOD2/CARD15 mutations in pediatric IBD (2003) (4)
- Sa1968 Post-Induction Adalimumab Drug Levels Predict Clinical and Laboratory Remission at Week 24 in Patients With Crohn's Disease (2016) (4)
- Sa1248 Late Adult-Onset Inflammatory Bowel Disease Patients Require Surgery Earlier During Their Disease Course Compared to Early Adult-Onset Patients (2012) (4)
- Corrigendum: Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants (2009) (4)
- The Toronto Ibd Global Endoscopic Reporting (Tiger) Score: A Single, Easy To Use Endoscopic Score For Both Crohn's Disease And Ulcerative Colitis Patients. (2021) (4)
- 638 5-Aminosalicylate (5-ASA) Induced Nephrotoxicity in Inflammatory Bowel Disease (2013) (4)
- 760 Divergence in L4 Crohn's Disease: Jejunal, Not Esophagogastroduodenal Involvement, is Protective of L2 Disease Location, and a Risk for Stricturing Behavior and Multiple Abdominal Surgeries. Report From the NIDDK-IBDGC Registry (2010) (4)
- Low bone mineral density (BMD) in Crohn's disease (CD) occurs independent of corticosteroid use (1998) (4)
- CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. (2022) (4)
- Ustekinumab induction concentrations are associated with clinical and biochemical outcomes at week 12 of treatment in Crohn’s disease (2021) (4)
- OP04 Vedolizumab intravenous is effective across multiple treatment targets in chronic pouchitis: Results of the randomised, double-blind, placebo-controlled EARNEST trial (2022) (4)
- Medication Adherence in Inflammatory Bowel Disease in the Global ALIGN Study: Impact of Concerns and Perceived Necessity of Immunosuppressants, 5-Aminosalicylates, and Tumor Necrosis Factor Inhibitors: 1872 (2015) (3)
- Defects in NADPH Oxidase Genes NOX 1 and DUOX 2 in Very Early Onset In fl ammatory Bowel Disease 65 66 67 68 (2015) (3)
- 439 - Toward Computer-Based Automated Mayo Score Classification in Ulcerative Colitis through Classical and Deep Machine Learning (2018) (3)
- Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium. (2022) (3)
- The NOD2 insC Risk Allele is Associated With Poor Pouch Outcome Following IPAA in Patients With Ulcerative Colitis (UC) (2011) (3)
- P311 Microscopic inflammation and myenteric plexitis at the margin of resection do not predict endoscopic recurrence in patients with Crohn's disease after ileocolic resection. (2017) (3)
- 96 – Increased Intestinal Permeability is a Predictor of Crohn's Disease Development in a Large Cohort of Asymptomatic First Degree Relatives (2019) (3)
- Genotype-phenotype analysis across 130 422 genetic variants identifies RSPO3 as the first genome-wide significant modifier gene in primary sclerosing cholangitis (2016) (3)
- Infliximab Induces Mucosal Healing in a Proximal to Distal Direction in Acute Ulcerative Colitis (2011) (3)
- Treatment of severe hidradenitis Suppurativa and Fistulizing Crohn’s disease with Guselkumab (2022) (3)
- Contribution of HLA class II genes to susceptibility to ulcerative colitis (UC) in a Canadian inflammatory bowel disease (IBD) population (1998) (3)
- Associations between quantitative evaluation of bowel wall microvascular flow by contrast‐enhanced ultrasound and indices of disease activity in Crohn's disease patients using both bolus and infusion techniques (2019) (3)
- T1745 A Prospective Multicenter Study of Outcomes and Predictors of Response in Severe Pediatric Ulcerative Colitis (2009) (3)
- Colorectal cancer risk in patients with inflammatory bowel disease and Lynch syndrome (2010) (3)
- 6 thiopurine induced pancreatitis in inflammatory bowel disease : clinical features and genetic determinants (2014) (3)
- (919): Cannabis use by patients with inflammatory bowel disease (2007) (2)
- Expression Changes of Xenobiotic Efflux Genes Are Associated With Ileal Inflammation in the Pelvic Pouch of Individuals With Ulcerative Colitis (2011) (2)
- 86 Association of Environmental Exposures With the Composition and Diversity of the Human Gut Microbiome in Healthy First Degree Relatives (FDR) of Crohn's Patients (2016) (2)
- A127 ANTI-TNF VS SURGICAL MANAGEMENT OF ABDOMINAL PHLEGMON IN CROHN’S DISEASE: A RETROSPECTIVE ANALYSIS (2018) (2)
- Corrigendum: Phenotypic and Genotypic Characteristics of Inflammatory Bowel Disease in French Canadians: Comparison With a Large North American Repository (2010) (2)
- Conducting Translational Gastrointestinal Research in the Era of COVID-19 (2020) (2)
- Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis (2016) (2)
- Erratum: Phenotypic and genotypic characteristics of inflammatory bowel disease in french canadians: Comparison with a large North American repository (Am J Gastroenterol (2009) 104 (2233-2240) (DOI: 10.1038/ajg.2009.267) (2010) (2)
- Genotype/phenotype correlations and implications for clinical practice. (2008) (2)
- Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease (2021) (2)
- Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn’s disease patients (2021) (2)
- Ulcerative Colitis Patients on Vedolizumab Lacking Response at Induction Phase Continue to Improve Over the First 6 Months of Treatment (2017) (2)
- P502 Ulcerative colitis patients on vedolizumab lacking response at induction phase continue to improve over the first 6 months of treatment. (2017) (2)
- 593 Predictive Value of Basal Plasmacytosis on Clinical Relapse in Quiescent Ulcerative Colitis (2015) (2)
- 847v 18 New Crohn's Disease Susceptibility Genes and Loci Identified by the International IBD Genetics Consortium (2010) (2)
- Challenges and Opportunities in IBD Clinical Trial Design. (2021) (2)
- Identifying novel high-impact rare disease-causing mutations, genes and pathways in exomes of Ashkenazi Jewish inflammatory bowel disease patients (2020) (2)
- AB0526 A novel approach to the early detection of axial spondyloarthritis in patients with inflammatory bowel disease: the implementation of an advanced practice physiotherapistled screening program (2013) (2)
- Serum Ustekinumab Concentrations Are Associated With Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index (2021) (2)
- Tu1962 Looking Beyond Symptoms and Disease Activity to Define Disease Severity in Inflammatory Bowel Disease: Results of an IOIBD Specialist Panel (2016) (2)
- CONTRIBUTION OF DLG5, MDR1, NOD1/CARD4 AND TLR4 TO PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE (2006) (2)
- Tu1316 Dose Optimization of Infliximab Using Therapeutic Drug Monitoring Is More Effective Than Dose Optimization Based on Clinical Assessment Alone in Patients With Active Inflammatory Bowel Disease (2015) (2)
- Tu1352 Use of Complementary Alternative Medicine for Inflammatory Bowel Disease Is Associated With Worse Adherence to Conventional Therapy (2015) (2)
- High Infliximab Levels are not Associated with a Higher Risk of Infection in IBD Patients (2017) (2)
- OC-010 Detailed analysis of ATG16L1 demonstrates gene-wide extent of association with crohn's disease susceptibility (2012) (1)
- 31 Putative Genetic Loci and Confirmation of Association in IBD (2010) (1)
- Sa1870 USTEKINUMAB LEVELS DIFFERENTIATE PATIENTS WITH ENDOSCOPICALLY ACTIVE AND INACTIVE CROHN'S DISEASE AS DEFINED USING A SERUM BASED ENDOSCOPIC HEALING INDEX (2020) (1)
- 259 Specific Crohn's Disease (CD) Associated Risk Alleles Are Associated With the Composition of the Intestinal Microbiota in Healthy First Degree Relatives (FDR) of CD Subjects (2013) (1)
- A9 BACTERIAL BILE SALT HYDROLASE GENE ABUNDANCE IS ASSOCIATED WITH RORC GENE EXPRESSION IN INTESTINAL MUCOSA OF INFLAMMATORY DISEASE PATIENTS (2020) (1)
- 203 Biomarkers Associated With Progressive Behaviour in Crohn's Disease (2010) (1)
- Tu1299 Higher Adalimumab Drug Levels Are Associated With Clinical and Endoscopic Remission in Patients With Crohn's Disease (2015) (1)
- Clinical and Genetic Markers of Disease Prognosis in Ulcerative Colitis (2011) (1)
- The Future of Molecular Approaches to Inflammatory Bowel Disease (2012) (1)
- A133 EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB INDUCTION THERAPY IN PATIENTS WITH ULCERATIVE COLITIS: REAL-WORLD EXPERIENCE IN A TERTIARY IBD CENTRE (2018) (1)
- Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn’s disease and leads to impaired CFB cleavage and phagocytosis (2023) (1)
- O-0026: African and European genetic admixture in African American IBD patients (2008) (1)
- Development and Validation of a Multi-marker Serum Test for the Assessment of Mucosal Healing in Crohnʼs Disease Patients: 600 (2017) (1)
- Complex host genetics influence the microbiome in inflammatory bowel disease (2014) (1)
- Introduction and Analysis 1: The genetic analysis of a complex disease (2002) (1)
- Israel–Gaza conflict (2009) (1)
- Sa1234 RNA-Seq Derived Whole Blood Gene Expression Signature As a Biomarker for Differential Diagnosis and Intestinal Inflammation in Inflammatory Bowel Disease (2014) (1)
- Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases (2022) (1)
- Tu1757 Intestinal Microbiota Is a Heritable Trait in Healthy Subjects (2014) (1)
- Su1786 A PBMC-Derived microRNA Signature Differentiates Colonic Crohn's Disease from Ulcerative Colitis (2016) (1)
- 391 Two Novel Polysaccharide Antibodies (Anti-Laminarin and Anti-Chitin) Predict An Aggressive Crohn's Disease Phenotype and Improve Differentiation Between Crohn's Disease and Ulcerative Colitis (2008) (1)
- African and European genetic admixture in African American IBD patients: O-0026. (2008) (1)
- 89 Ileal Pouch Symptoms Are Associated With Changes in Microbial Composition and Diversity Not Necessarily Related to Endoscopic Inflammation (2016) (1)
- The ileoanal pouch: the next frontier in inflammatory bowel disease. (2021) (1)
- Su1236 High Fecal Calprotectin Correlate With Active Colonic Disease but Not With Small Intestinal Crohn's Disease Activity (2015) (1)
- IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: the PROCTRIAL Consensus. (2022) (1)
- Phenotypic concordance and time clustering of diagnosis in multiply affected ibd families : the IOIBD Multiplex Family Collaborative Project, phases I a II (2005) (1)
- Genetics of inflammatory bowel disease: where are we? (2000) (1)
- Sa1959 Concentrations of 6-Thioguanine Nucleotide Correlate With Both Infliximab and Adalimumab Levels in Patients With Inflammatory Bowel Disease on Combination Therapy (2016) (1)
- 207 A Novel Algorithm-Based Approach Using Clinical Parameters, Genetic and Serological Markers to Effectively Predict Aggressive Disease Behavior in Patients With Crohn's Disease (2010) (1)
- Author Correction: Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel (2022) (1)
- Age at Diagnosis of Crohnʼs Disease May Explain NOD2-Smoking Interactions: 1975 (2015) (1)
- 565 Appendectomy and Extensive Disease Are Independent Predictors of Colectomy in Ulcerative Colitis: Results From a Large Cross-Sectional Cohort (2013) (1)
- New Insights Into the Genetic Basis for Variation in Crohn's Disease (CD) Phenotype in a Population-Based Study (2011) (1)
- Tu1928 A Peripheral Blood Derived microRNA Signature Reveals Molecular Differences in Patients With Endoscopically Quiescent Crohn's Disease Versus Healthy Controls (2016) (1)
- CONTRIBUTION OF SUSCEPTIBILITY GENES TO PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE: 204 (2005) (1)
- A101 USTEKINUMAB LEVELS MEASURED DURING INDUCTION ARE ASSOCIATED WITH CLINICAL AND BIOCHEMICAL OUTCOMES AT WEEK 12 OF TREATMENT IN CROHN’S DISEASE (2020) (1)
- A41 LOSS OF SATB2 EXPRESSION IN COLORECTAL CANCER IS ASSOCIATED WITH DURATION OF INFLAMMATORY BOWEL DISEASE (2020) (1)
- Increased Frequency of Risk Alleles in a Cohort of Healthy First Degree Relatives of Crohn's Disease Patients – A Report From the Michael J. Howorth/CCFC GEM Project (2011) (1)
- Mo1666 Inflammation and Symptoms of Pouchitis-Are They Correlated? (2012) (1)
- Prediction of Treatment Response in Crohn’s Disease Patients Using Contrast Enhanced Ultrasound: A Pilot Study (2017) (1)
- Tu1943 Higher Activity of the Inducible Nitric Oxide Synthase Contributes to Very Early Onset of Inflammatory Bowel Disease (2013) (1)
- Mo1840 Impact of Age on Beliefs About and Adherence to Medications in Patients With Inflammatory Bowel Disease: Results From the ALIGN Study (2016) (1)
- Phenotypic Predictors of Endoscopic Recurrence after Ileal Resection for Crohn'S Disease: An Niddk IBD Genetics Consortium Prospective Study (2017) (1)
- Colonic Vascular Prominence From Superior Mesenteric Vein Occlusion (2019) (1)
- Analysis of Inflammatory Bowel Disease-Associated Genetic Variants in a Healthy Manitoban First Nations Cohort (2011) (1)
- Su1805 THE LONG-TERM CORTICOSTEROID SPARING EFFECT OF ANTI-TNF THERAPY IN A REAL WORLD CROHN'S DISEASE COHORT (2020) (1)
- Interleukin-10 Receptor Gene Polymorphisms Associate with Early-Onset Inflammatory Bowel Disease (2011) (1)
- Antibody and T cell responses to SARS-CoV-2 mRNA vaccines during maintenance therapy for immune-mediated inflammatory diseases (2022) (1)
- 706 – A Prominent Role for Chemokines, in Particular Cxcl9, As Biomarkers Associated with Post-Operative Crohn's Disease Recurrence (2019) (1)
- 257 – Higher Abundance of Bile Acid-Metabolizing Microbiota is Associated with Type of Disease, Biopsy Location and Mucosal Inflammation in Inflammatory Bowel Disease Patients (2019) (1)
- A novel NFKB1 promoter polymorphism shows altered binding to nuclear proteins and increases risk for ulcerative colitis (2003) (1)
- Preoperative exposure to anti-tumor necrosis factor therapy in ulcerative colitis patients undergoing ileal pouch-anal anastomosis (IPAA) is not associated with histological fibrosis: A case control study. (2019) (1)
- DOP79 Biomarkers for IBD using OLINK Proteomics inflammation panel: Preliminary results from the COLLIBRI consortium (2022) (1)
- Mo1324 Association of a Panel of Anti-Microbial Antibodies With Disease Behavior and Response to Anti-TNF Therapy in a Cohort of Patients With Ulcerative Colitis (2013) (0)
- P269 Phenotypic predictors of endoscopic recurrence after ileal resection for Crohn's disease: an NIDDK IBD Genetics Consortium prospective study. (2017) (0)
- P426 Supra-therapeutic infliximab levels are not associated with a higher risk of infection in IBD patients. (2017) (0)
- A142 INTER-OBSERVER AGREEMENT AND THE ROLE OF EDUCATIONAL TRAINING ON THE ENDOSCOPIC SCORING OF CROHN’S DISEASE (2018) (0)
- 263 Characterization of the Tissue-Associated Microbiome in Active and Inactive IBD (2013) (0)
- Mo1241 Patterns of Extraintestinal Manifestations in Ulcerative Colitis and Crohn's Disease: Results From a Large Cross-Sectional Cohort (2013) (0)
- M1142 Phenotypic Variables Associated with Progression of Disease Behaviour in Crohn's Disease (2009) (0)
- Tu1831 – Use of Drug-Tolerant Assays in Inflammatory Bowel Disease; What Does It Tell Us? (2019) (0)
- 1107 Gene Expression Profiles Associated with Lack of Response to Intravenous Corticosteroids in Children with Severe Ulcerative Colitis (2009) (0)
- Mo1124 RNA-SEQ GENE EXPRESSION PROFILE REVEALS THAT DUOXA2 AND CCL11 GENES ARE ASSOCIATED WITH PROGRESSIVE RISK OF COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE PATIENTS (2020) (0)
- A26 USE OF DRUG-TOLERANT ASSAYS IN INFLAMMATORY BOWEL DISEASE; WHAT DOES IT TELL US? (2019) (0)
- Combined histo-endoscopic remission but not endoscopic healing alone in ulcerative colitis is associated with a mucosal transcriptional profile resembling healthy mucosa. (2022) (0)
- 761 MEGA-ANALYSIS REVEALS NOVEL GENETIC ASSOCIATIONS WITH EXTRAINTESTINAL MANIFESTATIONS IN IBD (2020) (0)
- 1050 Which Non-Invasive Disease Activity Index Should Be Used in Ulcerative Colitis? A Systematic Head-to-Head Psychometric Comparison (2009) (0)
- Sa1602: DISEASE OUTCOMES AFTER SEGMENTAL RESECTION OF COLONIC CROHN'S DISEASE: A RETROSPECTIVE MULTICENTER STUDY. (2022) (0)
- W1224 Genotypic Overlap Between Crohn's Disease (CD) and Ulcerative Colitis (UC) in a Large Cohort of Patients With Inflammatory Bowel Disease (IBD) (2010) (0)
- Efficacy of infliximab therapy for severe ulcerative colitis: P-047. (2008) (0)
- 833 DIETS HIGH IN OMEGA AND PLANT-DERIVED FATS, AND LOWER DIETARY INTAKE OF ISOMALT ARE ASSOCIATED WITH ENDOSCOPIC REMISSION AFTER ILEAL RESECTION FOR CROHN'S DISEASE (2020) (0)
- 150: BIOMARKERS FOR IBD USING OLINK PROTEOMICS INFLAMMATION PANEL: PRELIMINARY RESULTS FROM THE COLLIBRI CONSORTIUM (2022) (0)
- Sa1799 Evaluation of Location-Specific, Tissue-Associated Microbiota in the Ileal Pouch, Terminal Ileum and Colon in Inflammatory Bowel Disease (IBD) (2013) (0)
- A biological pathway approach to disease association studies: Toll receptor pathway alleles and susceptibility to inflammatory bowel disease (2006) (0)
- Tu1492: ILEAL MICROBIOME REMAINS LESS DIVERSE IN ENDOSCOPICALLY AND HISTOLOGICALLY INACTIVE CROHN'S DISEASE COMPARED TO ULCERATIVE COLITIS OR HEALTHY CONTROLS (2022) (0)
- Tu1906 EQTL Analysis Identifies Novel Associations Between Genotype and Gene Expression in the Human Intestine (2012) (0)
- M1151 Outcomes After Ileal Resection in Paediatric Crohn Disease: A 30 Year Single Center Experience (2008) (0)
- Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients (2023) (0)
- Mo1698 Clinical, Genetic and Serological Markers of Disease Behaviour in Colonic Inflammatory Bowel Disease (2012) (0)
- Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data (2019) (0)
- 975 Novel Associations of Uncommon Crohn's Disease Risk Alleles With Higher Frequencies in the Ashkenazi Jewish Population (2013) (0)
- A235 ILEAL MICROBIOME ALPHA DIVERSITY REMAINS LOWER IN ENDOSCOPICALLY AND HISTOLOGICALLY INACTIVE CROHN’S DISEASE COMPARED TO ULCERATIVE COLITIS OR HEALTHY CONTROLS (2022) (0)
- Effect of diagnostic misclassification on the ability to detect linkage in inflammatory bowel disease (IBD) (2000) (0)
- Mo1676 Life Events as a Predictor of Inflammatory Bowel Disease Activity and Quality of Life (2012) (0)
- Outcome After Pelvic Pouch Surgery is Associated With Differences in the Microbiome as Characterized by 16s rRNA Pyrosequencing (2011) (0)
- Mo1107 THE GEM PROJECT: CROHN'S DISEASE POLYGENIC RISK SCORE IS ASSOCIATED WITH PRECLINICAL INFLAMMATION IN ASYMPTOMATIC FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS (2020) (0)
- Su1859 – Real-World Effectiveness and Safety of Vedolizumab and Anti-TNF in Biologic-Naive Crohn’s Disease Patients: Results from the Evolve Study (2019) (0)
- 322 Chromatin Accessibility Differences Between CD4 T-Cells From Inflamed or Non-Inflamed Regions of the Gut in Inflammatory Bowel Diseases (2016) (0)
- X. Challenges update workgroups (2008) (0)
- Mo1836 – Can Crohn’s Patients Be Accurately Phenotyped Based on Operative and Pathology Review At Time of Ileal Resection? (2019) (0)
- Tu1744 The Relationship Between Common IBD-Associated Risk Alleles and Intestinal Permeability in a Cohort of Healthy First Degree Relatives of Individuals With Crohn's Disease (2013) (0)
- Su1892 - Factors Associated with Intestinal Resection in Crohn's Disease Patients with Bowel Damage Progression as Assessed by Lemann Index (2018) (0)
- ssociation of Trough Serum Infliximab to Clinical Outcome After Scheduled aintenance Treatment for Crohn ’ s Disease (0)
- 374 INFLAMED ULCERATIVE COLITIS REGIONS ASSOCIATED TO MRGPRX2-MEDIATED MAST CELL DEGRANULATION AND CELL ACTIVATION MODULES, DEFINING A NEW THERAPEUTIC TARGET (0)
- Mo1486: MANAGEMENT OF POUCH NEOPLASIA: A CONSENSUS GUIDELINE FROM THE INTERNATIONAL ILEAL POUCH CONSORTIUM (2022) (0)
- Measurement of Disease Activity of Pouchitis (2022) (0)
- Existing Bowel Preparation Quality Scales Are Reliable in the Setting of Centralized Endoscopy Reading (2022) (0)
- Mo1594: ILEAL INVOLVEMENT DEFINED BY THE MONTREAL CLASSIFICATION IN CROHN’S DISEASE IS ASSOCIATED WITH A DISTINCT MICROBIAL COMPOSITION IN ILEAL AND COLONIC MUCOSA (2022) (0)
- P687 Genetic associations with high-grade dysplasia and colorectal cancer in patients with colonic inflammatory bowel disease: preliminary results from ImmunoChip using a targeted analytic approach (2013) (0)
- Combination agents target early, late stages of allergy (2003) (0)
- P297 The Toronto IBD Global Endoscopic Reporting (TIGER) Score and its Ability to Predict Outcomes Regarding Steroid and Biologic Use in Ulcerative Colitis and Crohn’s Disease Patients – A Construct Validation Study (2023) (0)
- 776 IDENTIFYING NOVEL HIGH-IMPACT RARE DISEASE-CAUSING MUTATIONS, GENES AND PATHWAYS IN EXOMES OF ASHKENAZI JEWISH INFLAMMATORY BOWEL DISEASE PATIENT (0)
- Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2020) (0)
- Tu1929 Association of Macro/Micro Nutrients With Endoscopic Disease Activity in Patients With Inflammatory Bowel Disease Suggests Possible Protective Role for Dietary Components (2016) (0)
- A181 HIGHER CUMULATIVE HISTOLOGIC INFLAMMATORY BURDEN SCORE IS ASSOCIATED WITH THE RISK OF DEVELOPMENT OF COLORECTAL NEOPLASIA IN ULCERATIVE COLITIS (2023) (0)
- Sa482 MEGA-ANALYSIS REVEALS CLINICAL SEROLOGICAL AND GENETIC ASSOCIATIONS WITH EXTRAINTESTINAL MANIFESTATIONS IN IBD (2021) (0)
- Vedolizumab for the Treatment of Chronic Pouchitis. (2023) (0)
- 124 Exome Analyses Identify Novel Inflammatory Bowel Disease-Associated Genetic Variants (2014) (0)
- Sa1871 USTEKINUMAB LEVELS MEASURED DURING INDUCTION ARE ASSOCIATED WITH CLINICAL AND BIOCHEMICAL OUTCOMES AT WEEK 12 OF TREATMENT IN CROHN'S DISEASE (2020) (0)
- Mo1121 TARGETED MUCOSAL TRANSCRIPTOMICS ANALYSIS REVEALS DIFFERENTIAL EXPRESSION OF CARNITINE, TRIMETHYLAMINE AND TRIMETHYLAMINE-N-OXIDE GENE PATHWAYS IN INFLAMMATORY BOWEL DISEASE (2020) (0)
- Clinical Features and Treatment Outcomes in Hidradenitis Suppurativa With Fistulizing Crohn’s Disease: A Systematic Review (2022) (0)
- Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients (2023) (0)
- Evaluation of the Pouch Microbiome Using RT-PCR Identifies Specific Microbial Elements Associated With Outcome (2011) (0)
- Future directions in inflammatory bowel disease management ☆ ded from h (2014) (0)
- A108 EARLY ALBUMIN LEVEL IS ASSOCIATED WITH TIME TO COLECTOMY AND RE-ADMISSION RISKS IN HOSPITALIZED ULCERATIVE COLITIS PATIENTS STARTING INFLIXIMAB (2019) (0)
- P671 An IL23R risk variant is associated with changes in CD4+ T-cell subsets in peripheral blood of Crohn's disease patients (2013) (0)
- Mo1248 Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease (2014) (0)
- Sa2039 Does Anti-TNF-Alpha Therapy Affect the Morphology of Crohn's Disease? (2012) (0)
- IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes (2018) (0)
- Determinants of corticosteroid-resistance in severe pediatric ulcerative colitis: P-0038. (2009) (0)
- 780 HOST SEROREACTIVITY TO MICROBIAL ANTIGENS IS ASSOCIATED WITH FUTURE ONSET OF CROHN'S DISEASE INDEPENDENT OF GUT BARRIER FUNCTION, SUBCLINICAL INFLAMMATION, AND GENETIC RISK (2021) (0)
- 1105 Serum gASCA, Anti-L and Smoking Status Are Associated with Crohn's Disease-Like Phenotype After Pelvic Pouch Surgery for Ulcerative Colitis (2009) (0)
- What Constitutes Frailty In Inflammatory Bowel Disease? (2020) (0)
- Tu1708 Associations Between Host Transcription and the Intestinal Microbiome (2013) (0)
- Su1216 Low Fecal Calprotectin Correlates With Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease (2015) (0)
- P189 Prospective Validation Study Regarding Disease Complications of the Toronto IBD Global Endoscopic Reporting (TIGER) Score in Ulcerative Colitis and Crohn’s Disease Patients (2023) (0)
- Su1778 – The Toronto IBD Global Endoscopic Reporting (Tiger) Score: A Single, Easy to Use Endoscopic Score for All IBD Patients (2019) (0)
- acute ulcerative colitis clinical outcome for infliximab treatment in Trough serum infliximab : a predictive factor of (2009) (0)
- Mo1506: LOWER SERUM CONCENTRATION OF SULFATED BILE ACIDS IS ASSOCIATED WITH PRIMARY SCLEROSING CHOLANGITIS INFLAMMATORY BOWEL DISEASE COMORBIDITY AND ADVANCED LIVER FIBROSIS (2022) (0)
- 168 GENE EXPRESSION ANALYSES IN THE PERIOPERATIVE ILEAL RESECTION PERIOD ILLUMINATE PATHOGENIC AND PROTECTIVE CROHN'S DISEASE CELL SUBSETS (2021) (0)
- Su1017: MALE GENDER AND NON-CAUCASIAN ETHNICITY ARE ASSOCIATED WITH HIGHER RISK OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE INDEPENDENT OF KNOWN CLINICAL RISK FACTORS (2022) (0)
- A221 CROHN’S DISEASE POLYGENIC RISK SCORE IS ASSOCIATED WITH FECAL CALPROTECTIN CONCENTRATION IN ASYMPTOMATIC FIRST-DEGREE RELATIVES OF CROHN’S DISEASE PATIENTS (2020) (0)
- Mo1240 Do Genetic Markers Predict a Progressive Disease Course in Crohn's Disease? (2014) (0)
- 836 Genetic Associations With High-grade Dysplasia and Colorectal Cancer in Patients With Colonic Inflammatory Bowel Disease: Preliminary Results From Immunochip Using a Targeted Analytic Approach (2013) (0)
- Sa1757 Autophagy Regulates Expression of the RISC Component Ago2 a Critical Regulator of the miRNA Silencing Pathway (2013) (0)
- The Utility of Genetics in Classifying Ulcerative Colitis and Crohn's Disease Patients (2011) (0)
- P009 Determinants of Corticosteroid-Resistance in Severe Pediatric Ulcerative Colitis (2009) (0)
- Su1900 Association of Functional Capacity of Fecal Microbiota With Intestinal Permeability in Healthy First Degree Relatives of Crohn's Disease Patients (2016) (0)
- 108 – The Prevalence and Use of Cannabis by Patients with Inflammatory Bowel Disease (2019) (0)
- Su1905 – B2 Stricturing Behavior Associated with TGF and Stromal Cell Survival Proteins in the Preoperative Period (2019) (0)
- Mo1797 LOSS OF SATB2 EXPRESSION IN COLORECTAL CANCER IS ASSOCIATED WITH DURATION OF INFLAMMATORY BOWEL DISEASE (2020) (0)
- P698 Characterization of the tissue-associated microbiome in active and inactive IBD (2013) (0)
- P675 A locus on chromosome 8q24 near MYC and anti-OmpC are associated with perianal Crohn's disease (2013) (0)
- P066 Lower serum concentration of sulfated bile acids is associated with Primary Sclerosing Cholangitis Inflammatory Bowel Disease comorbidity and advanced liver fibrosis (2022) (0)
- P273 Prediction of treatment response in Crohn's disease patients using contrast enhanced ultrasound: a pilot study. (2017) (0)
- P609 5-Aminosalicylate (5-ASA) induced nephrotoxicity in inflammatory bowel disease (2013) (0)
- P050 Centrally-determined standardization of flow cytometry methods reduces inter-laboratory variation in a prospective multicenter study. (2017) (0)
- 584: VEDOLIZUMAB INTRAVENOUS IS EFFECTIVE ACROSS MULTIPLE TREATMENT TARGETS IN CHRONIC POUCHITIS: RESULTS OF THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED EARNEST TRIAL (2022) (0)
- A5 ASSOCIATION ANALYSIS BETWEEN BILE ACID-METABOLIZING MICROBIOTA ABUNDANCE AND ENDOSCOPIC INFLAMMATION IN INFLAMMATORY BOWEL DISEASE PATIENTS (2019) (0)
- Tu1905 Interaction of IBD-Associated Genetic Polymorphisms and the Microbiome of the Pelvic Pouch (2012) (0)
- Shorter Time Interval From Exposure to Biological Treatment to Surgery in Patients With IBD is Not Associated With Increased Short-Term Surgical Complications (2011) (0)
- Sa1170 - Mir-874-3P Suppresses Atg16L1 In Vitro During Rapamycin Induced Autophagy (2018) (0)
- 744 Genome-Wide Association of Composition and Diversity of the Intestinal Bacterial Phyla in Healthy First Degree Relatives (FDR) of Crohn's Disease (CD) Subjects (2015) (0)
- Increased Dietary Carbohydrate is Associated with Clinical Activity and with Endoscopic Remission in Inflammatory Bowel Disease (2017) (0)
- P588 Interim results from the randomised VERDICT trial to determine the optimal treatment target in patients with ulcerative colitis (2023) (0)
- Phenotypic variables associated with progression of disease behaviour In Crohnʼs Disease: P-0040. (2009) (0)
- polymorphism in Lithuanian inflammatory patients associations with high-grade dysplasia and colorectal cancer in patients with colonic inflammatory bowel disease: preliminary results from ImmunoChip using a targeted analytic approach (2013) (0)
- Su1884 Influence of the Microbiome on Epigenetic Mechanisms in Inflammatory Bowel Disease (IBD) (2016) (0)
- Correction: Colonic Vascular Prominence From Superior Mesenteric Vein Occlusion. (2019) (0)
- Tu1545: TRANS-CONTINENTAL ANALYSIS OF OVER 2,000 INFLAMMATORY BOWEL DISEASE PATIENTS IMPLICATES GEOGRAPHY, DISEASE TYPE, AND EXPOSURE TO IMMUNOSUPPRESSION AS DRIVERS OF SARS-COV-2 SEROPREVALENCE (2022) (0)
- Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis (2023) (0)
- Genetic and environmental factors associated with diminished bone mineral density (BMD) differ in ulcerative colitis and Crohn's disease (2001) (0)
- Diagnostic misclassification of patients with presumed inflammatory bowel disease (IBD) (2000) (0)
- P342 Trans-continental analysis of over, 2000 Inflammatory Bowel Disease patients implicates geography, disease type, and exposure to immunosuppression as drivers of SARS-CoV-2 seroprevalence: data from the ICARUS-IBD Consortium (2022) (0)
- P268 Development and validation of a novel composite index for the assessment of endoscopic and histologic disease activity in pouchitis: The Atlantic pouchitis index (2023) (0)
- A66 CHARACTERIZATION OF PERIPHERAL BLOOD AND LAMINA PROPRIA LYMPHOCYTES IN CROHN’S DISEASE. (2018) (0)
- Su1323 Patients With Crohn's Disease Who Never Smoke Are More Likely to Carry NOD2 Variants: A Case-Only NOD2-Smoking Interaction Study (2015) (0)
- OP29 Peri-natal exposure to parental Crohn’s disease is associated with impaired gut barrier, microbiome composition differences and increased risk of Crohn’s disease (2023) (0)
- Sa1733 - Higher Added Sugar and Lower Mono-Unsaturated Fat Intake is Associated with Post-Operative Crohn's Disease Recurrence after Ileal Resection: An Niddk IBD Genetics Consortium Prospective Study (2018) (0)
- 838 A Locus on Chromosome 8q24 Near MYC and Anti-OmpC Are Associated With Perianal Crohn's Disease (2013) (0)
- Su1832 Sacroiliitis is underrecognized in Inflammatory Bowel Disease and is Associated With Previous Arthritis and Inflammatory Crohn's Phenotype (2016) (0)
- Centrally-Determined Standardization of Flow Cytometry Methods Reduces Inter-Laboratory Variation in a Prospective Multicenter Study (2017) (0)
- Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis (2021) (0)
- W1226 Trough Serum Infliximab Predicts Outcome for Ulcerative Colitis Treatment with Infliximab (2008) (0)
- P0128 PP CONTRIBUTION OF CARD15 AND IBD5 (5Q31) LOCI TO PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE (2004) (0)
- Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn's Disease. (2016) (0)
- Tu1827 – Maintenance Levels of Vedolizumab Do Not Correlate with Clinical Remission in IBD Patients (2019) (0)
- Mo1241 Has the Time to First Abdominal Surgery for Crohn's Disease Reduced With Early Immunosuppressant Therapy? (2014) (0)
- DOP06 Histologic activity in Ulcerative Colitis patients achieving endoscopic healing is associated with higher rate of relapse and a distinct mucosal microbial and transcriptional profile (2021) (0)
- Su1331 Stricturing/Penetrating Crohn's Disease at Diagnosis - Does It Predict an Aggressive Disease Course? (2015) (0)
- P793 Microbial composition in IBD may influence clinical symptoms independent of endoscopic activity. (2017) (0)
- University of Groningen Complex host genetics influence the microbiome in inflammatory bowel disease (2017) (0)
- A236 ASSOCIATION OF STOOL METABOLOMIC PROFILE AND MICROBIOME COMPOSITION RISK SCORE WITH FUTURE ONSET OF CROHN’S DISEASE (2022) (0)
- Su1893 - Patients with Persistently Clinically Silent Crohn's Disease can have Insidious, but Uneventful, Progression of Bowel Damage Due to small Bowel Stricturing as Assessed by Lemann Index (2018) (0)
- P615 The unfinished symphony: golimumab is efficient in patients with refractory Crohn's disease. (2017) (0)
- Tu1920 Predictors and Characteristics of Psoriasiform Skin Lesions While on Infliximab Among Patients With Inflammatory Bowel Disease (IBD) (2016) (0)
- P310 Added value of anti CBir-1 antibodies to differentiate IBD unclassified from ulcerative colitis (2013) (0)
- 135 THE GEM PROJECT: DIETARY PATTERNS ARE ASSOCIATED WITH MICROBIOME COMPOSITION AND INTESTINAL INFLAMMATION IN HEALHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS (2020) (0)
- Tu1548: IMMUNE RESPONSE AFTER COVID-19 VACCINATION DURING MAINTANACE THERAPY IN IMMUNE-MEDIATED INFLAMMATORY DISEASES: AN OBSERVATIONAL COHORT STUDY (2022) (0)
- A156 MUCOSA-ASSOCIATED MICROBIOTA OF ILEOCOLONIC CROHN’S DISEASE PATIENTS IS DISTINCT FROM COLONIC CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS INDEPENDENT OF BIOPSY SITE, ENDOSCOPIC INFLAMMATION AND HOST GENETICS (2022) (0)
- Microbial Composition in IBD May Influence Clinical Symptoms Independent of Endoscopic Activity (2017) (0)
- Tu1797 - Multi-Center Cohort Analysis Identified a Genetic Association in Complement Factor B with Perianal Crohn's Disease (2018) (0)
- Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2022) (0)
- P700 Evaluation of location-specific, tissue-associated microbiota in the ileal pouch, terminal ileum and colon in inflammatory bowel disease (IBD) (2013) (0)
- Infliximab induces mucosal healing in a proximal to distal direction in acute ulcerative colitis. (2011) (0)
- The Interaction Between NOD2 and Smoking Is Specific to the 1007fs SNP of the NOD2 Gene in Crohnʼs Disease: A Systematic Review and Meta-analysis: 1979 (2015) (0)
- A100 THE UNFINISHED SYMPHONY: GOLIMUMAB IS EFFICIENT AS SALVAGE THERAPY IN PATIENTS WITH REFRACTORY CROHN’S DISEASE (2018) (0)
- Mo1117 INCREASED ABUNDANCE OF BACTERIAL BILE SALT HYDROLASE GENES IS ASSOCIATED WITH MUCOSAL RORγT GENE EXPRESSION IN INFLAMMATORY BOWEL DISEASE PATIENTS. (2020) (0)
- 555: MUCOSAL MICROBIAL PROFILES AT THE NEO-TERMINAL ILEUM ARE ASSOCIATED WITH FUTURE DEVELOPMENT OF POSTOPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE PATIENTS. (2022) (0)
- P146 The Toronto IBD global endoscopic reporting (TIGER) score demonstrates significant correlation with fecal calprotectin, CRP and IBD Disk in Crohn’s disease patients (2021) (0)
- Su1176 Added Value of Anti-Cbir-1 Antibodies to Differentiate IBD Unclassified From Ulcerative Colitis (2013) (0)
- P-175 Pleiotropic Effects of Novel Functional LRRK2 Variation on Crohn's Disease and Parkinson's Disease Risk (2016) (0)
- P688 Associations between host transcription and the intestinal microbiome (2013) (0)
- Whole Genome Association Identifies Novel Susceptibility Genes for Crohn's Disease and Implicates a Crucial Role for Autophagy (2007) (0)
- The future of molecular approaches to inflammatory bowel disease. (2009) (0)
- Microrna Expression Patterns Associated with Tissue Location in Endoscopically Quiescent Crohn's Disease Versus Healthy Controls Suggest Alterations to Innate Immunological Response (2017) (0)
- 713f Histologic Activity in Ulcerative Colitis Patients Achieving Endoscopic Healing is Associated with Higher Rate of Relapse and a Distinct Mucosal Microbial and Transcriptional Profile (2021) (0)
- P437 Higher adalimumab maintenance regimens are more effective than standard maintenance doses in Crohn’s disease patients who have failed infliximab (2018) (0)
- Genetic susceptibility in a Canadian inflammatory bowel disease (IBD) population (1998) (0)
- P690 Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis (2013) (0)
- P223 C-reactive protein improvement after vedolizumab induction phase is associated with remission after 6 months of treatment in ulcerative colitis patients. (2017) (0)
- A35 GENOME WIDE ASSOCIATION STUDY OF ABNORMAL INTESTINAL PERMEABILITY IN HEALTHY FIRST DEGREE RELATIVES OF CROHN’S PATIENTS (2018) (0)
- A genome-wide scan in a canadian inflammatory bowel disease (IBD) population reveals two novel susceptibility loci (2000) (0)
- Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease (2015) (0)
- NADPH oxidase complex and IBD Candidate Gene studies: O-18. (2011) (0)
- Su1269 Preoperative Anti TNF α Therapy in Ulcerative Colitis Patients Is Not Associated With an Increased Risk of Post Operative Ileal Pouch-Anal Anastomosis (IPAA) Leaks and Infectious Complications (2015) (0)
- VI. Report of specific IBD diagnoses workgroup (2008) (0)
- Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease. (2023) (0)
- 1025 Development of the Modified Harvey-Bradshaw Index (mHBI) Score, HBI-PRO, to Assess Disease Activity in Crohn's Disease (2015) (0)
- S1173 Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Crohn's Disease (2010) (0)
- Tu1264 Intolerance of Uncertainty and Quality of Life in Patients With Ulcerative Colitis (2015) (0)
- A135 MICROBIOME IN CROHN’S DISEASE PATIENTS: A COMPILATION OF PUBLICLY AVAILABLE DATASETS (2018) (0)
- Su1412 Is There a Higher Rate of Infliximab Dose Optimization in Initial Responders Between UC and CD Cases (2014) (0)
- 33 The GTPase RAC1 is Associated With Inflammatory Bowel Disease (2010) (0)
- Identification of two novel susceptibility loci in a Canadian inflammatory bowel disease population (2000) (0)
- A101 NO ASSOCIATION WITH RISK OF INFECTION IN IBD WITH HIGH SERUM INFLIXIMAB LEVELS (2018) (0)
- 694 Age Specific Genetic Variations in Very Early Onset Inflammatory Bowel Disease (2013) (0)
- 475 - Clinical Predictors of Recurrence after End Ileostomy and Colectomy for Crohn's Disease (2018) (0)
- W1214 Genetic Polymorphisms, Serum Anti-Flagellin and ASCA are Associated With Outcome Following Ileal Pouch-Anal Anastomosis (IPAA) (2010) (0)
- OP08 Mucosal healing with vedolizumab in inflammatory bowel disease patients with chronic pouchitis: Evidence from EARNEST, a randomized, double-blind, placebo-controlled trial (2023) (0)
- S1213 Comparative Characteristics of Inflammatory Bowel Disease (IBD) in Individuals of South Asian, Jewish and Caucasian Ethnic Backgrounds (2010) (0)
- Significance of fundic gland polyp carpeting in familial adenomatous polyposis (2003) (0)
- Higher Adalimumab Maintenance Regimens Are More Effective Than Standard Maintenance Regimens in Crohnʼs Disease Patients Who Have Failed Infliximab: 745 (2017) (0)
- Do Genes Matter (2017) (0)
- P584 Efficacy, safety, and tolerability of AMT-101, a gut selective oral IL-10 fusion, in the Phase 2 FILLMORE trial of patients with chronic pouchitis (2023) (0)
- DOP011 A genome wide association study identifying association of the MHC region with 5-aminosalicylate (5-ASA) induced nephrotoxicity in inflammatory bowel disease (2014) (0)
- 126 Fine Mapping the Association of IL23R SNPs With Microbiota Composition in Healthy Subjects (2014) (0)
- Sa1866 LOW DRUG CONCENTRATIONS AND ANTI-DRUG ANTIBODY FORMATION TO THE PRIOR ANTI-TNF PREDISPOSES PATIENTS WITH INFLAMMATORY BOWEL DISEASE TO DEVELOP ANTI-DRUG ANTIBODIES TO THE SUBSEQUENT ANTI-TNF (2020) (0)
- W1226 An IRGM Variant is Associated With Development of Anti-Microbial Antibodies in Crohn's Disease (2010) (0)
- Abstracts of the 12th Congress of ECCO – European Crohn’s and Colitis Organisation S485 P791 Activation of the aryl hydrocarbon receptor after simvastatin and recombinant antagonist of receptors of interleukin-1 treatment in a rat model of inflammatory bowel disease (0)
- P313 A composite serological panel predicts burden of inflammation in Crohn's disease (2013) (0)
- DOP63 The Toronto IBD global endoscopic reporting (TIGER) score is well correlated with fecal calprotectin and IBD Disk in Ulcerative Colitis patients (2021) (0)
- Mo1795 Environmental and Demographic Factors Are Associated With the Composition of Human Gut Microbiome in Healthy FDR of Crohn's Patients (2015) (0)
- A88 A PROSPECTIVE STUDY OF MECHANISMS OF INTESTINAL INFLAMMATION AFTER ILEAL RESECTION IN CROHN’S DISEASE: PRELIMINARY ANALYSIS OF PHENOTYPIC PREDICTORS OF ENDOSCOPIC RECURRENCE (2018) (0)
- Correction (2015) (0)
- P708 Ileal involvement defined by Montreal classification in Crohn’s disease is associated with a distinct microbial composition in ileal and colonic mucosa (2022) (0)
- Su1008 – Mir874-3P is Inversely Correlated with Its Target Atg16L1 in T-Cells of Inflammatory Bowel Disease Patients (2019) (0)
- P899 Analysis of IL-23 receptor genetic variants associations with gut microbiome composition and barrier function in a cohort of healthy first-degree relatives of subjects with Crohn's disease (2023) (0)
- Su1276 Use of Anti-TNF Therapy in Patients With Crohn's Disease Complicated by an Abdominal Phlegmon (2015) (0)
- adherence with may CBir-1 antibodies to differentiate IBD unclassified from ulcerative colitis (2013) (0)
- 97 Detailed Analysis of ATG16L1 Demonstrates Gene-Wide Extent of Association With Crohn's Disease Susceptibility (2012) (0)
- Mo1333 The Impact of Diet on Post-Operative Recurrence Following Ileal Resection in Crohn's Disease (2013) (0)
- Mo1515: THE TRANSCRIPTOMIC PROFILE OF THE NON-INFLAMED ILEUM IN CROHN’S DISEASE DIFFERS COMPARED TO THAT OF HEALTH CONTROLS (2022) (0)
- Persistent Symptoms, CRP Elevation and Treatment Changes Over Time in Crohn's Disease Patients are Associated with Bowel Damage Progression as Expressed by Deterioration of Lemann Index Score (2017) (0)
- 128 Evaluation of Genetic and Microbial Determinants of Intestinal Permeability in Healthy First Degree Relatives of Crohn's Disease (2014) (0)
- P664 Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD (2023) (0)
- Genetic Factors in the Pathogenesis of Inflammatory Pouch Disorders (2019) (0)
- Sa1918 Better off Naïve: Predictors of Adalimumab Dose Escalation in Patients With Crohn's Disease (2012) (0)
- P296 Persistent symptoms, CRP elevation and treatment changes over time in Crohn's disease patients are associated with bowel damage progression as expressed by deterioration of Lemann Index score. (2017) (0)
- P270 A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease (2023) (0)
- Risk factors for bone loss in Crohn's disease (2000) (0)
- Tu1758 Intestinal Microbiota Makeup Is Not Associated With NOD2 and FUT2 Genetic Polymorphisms in a Healthy Cohort (2014) (0)
- A161 MUCOSAL TRANSCRIPTOMICS IN NON-INFLAMED ILEUM OF CROHN’S DISEASE PATIENTS SHOWS DIFFERENTIALLY EXPRESSED GENE PROFILE COMPARED TO ILEUM OF HEALTHY CONTROLS (2022) (0)
- P700 The GEM Project: Stool metabolomic profile is associated with microbiome risk score and with future onset of Crohn’s disease in healthy first-degree relatives (2022) (0)
- Su1751 Genetic Markers of Medically-Refractory Ulcerative Colitis and Proximal Disease Extension on Long-Term Follow-up – A Genome-Wide Association Study (2013) (0)
- Sa.137. Toll-Like Receptor Pathway Polymorphisms and Association to Inflammatory Bowel Disease (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mark. S. Silverberg?
Mark. S. Silverberg is affiliated with the following schools: